Breast cancer is classified by the gene expression profiles into intrinsic subtypes, such as luminal A, luminal B, HER2 (human epidermal growth factor receptor 2), and basal-like, which possess distinct biological properties, drug responses, and patient outcomes [1, 4–6]. The gene discussed is ERBB2; the disease is breast carcinoma.